Carole Huntsman sold $1.1M of MDGL
Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC.. 1,958 shares at an average of $553.11, traded Nov 21, 2025, filed Nov 21, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.1M at market
- +5Share of holdings soldSold 16% of holdings
- +15Cluster4 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-053648, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -894 | $550.97 | $493k | 11,096 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -144 | $547.27 | $79k | 10,952 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -120 | $548.71 | $66k | 10,832 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -40 | $549.34 | $22k | 10,792 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -200 | $552.38 | $110k | 10,592 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -40 | $553.23 | $22k | 10,552 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -120 | $556.04 | $67k | 10,432 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -200 | $559.60 | $112k | 10,232 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -80 | $560.62 | $45k | 10,152 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -40 | $563.21 | $23k | 10,112 | Nov 21, 2025 |
| Nov 21, 2025 | SOpen-market sale Common Stock10b5-1 | -80 | $564.57 | $45k | 10,032 | Nov 21, 2025 |
Related signals
Other insiders at MADRIGAL PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | MADRIGAL PHARMACEUTICALS, INC. | William John Sibold President and CEO | $6.2M 11,583 shares | -6% | |
| 45Moderate | MADRIGAL PHARMACEUTICALS, INC. | Mardi Dier EVP and CFO | $854k 1,982 shares | -14% | |
| 42Moderate | MADRIGAL PHARMACEUTICALS, INC. | Carole Huntsman Chief Commercial Officer | $181k 419 shares | -3% | |
| 41Moderate | MADRIGAL PHARMACEUTICALS, INC. | Shannon T Kelley General Counsel | $155k 360 shares | -3% | |
| 42Moderate | MADRIGAL PHARMACEUTICALS, INC. | Rebecca Taub director | $212k 491 shares | -0% | |
| 61Notable | MADRIGAL PHARMACEUTICALS, INC. | William John Sibold President and CEO | $718k 1,663 shares | -1% | |
| 60Notable | MADRIGAL PHARMACEUTICALS, INC. | Mardi Dier EVP and CFO | $505k 1,183 shares | -11% | |
| 27Weak | MADRIGAL PHARMACEUTICALS, INC. | Carole Huntsman Chief Commercial Officer | $449k 910 shares | -9% | |
| 44Moderate | MADRIGAL PHARMACEUTICALS, INC. | Rebecca Taub director | $319k 647 shares | -0% | |
| 62Notable | MADRIGAL PHARMACEUTICALS, INC. | William John Sibold President and CEO | $777k 1,577 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.